GOLD STANDARD

Newly available from your consultant or GP: From a single sample there is now a triple-combination test using the new technique of liquid-based cytology which, in addition to your routine smear, tests for HPV and chlamydia.

Virtually all cervical cancers are caused by the human papilloma virus (HPV). HPV is the most common sexually transmitted disease and can occur at any age. Most sexually active adults have been infected with HPV at some point in their lives. Most will never know because there are no symptoms and the body fights it off. But if it lingers in the cervix, HPV can cause changes that will lead to cervical cancer. Therefore, testing for HPV alongside the routine cervical smear test identifies women who are at risk, is reassuring for those who are low risk, and helps reduce missed disease caused by false negative smear tests.

Chlamydia is an infection of the reproductive organs. It is a common condition and there are no clear risk factors. It often occurs in young adults; simply changing sexual partners can put anyone at risk. If chlamydia is not diagnosed soon after infection, complications may occur in both men and women. In females, symptoms include vaginal discharge, burning when passing urine and lower abdominal pain. Infection may also be present in the throat and rectum. In both of these sites, there are usually no symptoms. If chlamydia is not treated, conditions may arise which may result in infertility or ectopic pregnancy. However, it can be simply and effectively treated.

Your consultant or GP can tell you more about this newly available combination test.

 

Follow Histopath_IHS on Twitter

LATEST NEWS:

Archive  
Roche Strikes HPV Test Co-marketing Deal with Unilabs January 2012 NEW YORK (GenomeWeb News) – Roche today said that it has signed a co-marketing .......
 
Now registered by the Care Quality Commission March 2011 Unilabs- I.H.S is now registered by the Care Quality Commission under the Health and Social Care Act 2008.......
 
Launch of Roche cobas 4800 system February 2011 I.H.S is working in association with Roche and the new state-of-the-art, fully automated Cobas 4800 system......
 
Important Developments in Gynaecological Cellular Pathology October 2010 IHS is working in association with Roche and its leading edge Cobas 4800 System......
Our Services Online Pathology IHSCONNECT